Whitepaper Downloads

What is the Best Way for Manufacturers and Physicians to Apply Sunscreen to Avoid Being Burned by the Final Sunshine Act Regulations?

Author: Abraham Gitterman, Associate, Arnold & Porter, LLP

Download Whitepaper. 


Speaker Interviews

Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate Biopharma's Approach, Part I.

Co-Authors:
David Knepper, Head, Continuous Improvement, Forest Laboratories
Andy Lawton, Global Head, Data Management, Biometrics & Data Management, Boehringer Ingelheim Ltd.

Read Article  

Technology Considerations to Enable the Risk-Based Monitoring Methodology

Contributing Author: Shelly Barnes, Senior Project Manager, Global Clinical Solution Center – Strategy and Innovation, Sanofi

Read Article 


Interviews

Preparing CRAs to be Site Recruitment Managers: The Pros, the Cons and The Process

With: Beth Harper, President, Consultant, CPP, Inc.
Nikki Christison, President, Consultant, Clinical Resolutions, Inc.
Gretchen Goller, Senior Director, Patient Access and Retention Services, PRA International

Read Interview 


Podcasts

Postmarketing Regulatory Environment in Europe and the Role of Observational Studies in Drug Risk-Benefit Studies

Vera Ehrenstein, MPH, DSc, Associate Professor, Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University

Amid Zand Interview Dr. Vera Ehrenstein of Aarhus University (Denmark) on December 27, 2014. Dr. Ehrenstein will be speaking at the SCOPE Summit in Orlando, FL in a track titled managing late stage research, observational studies and registries. Her talk will focus on collaborating with regulatory bodies such as the EMA on risk-minimization studies.

Click Here to Download 

Effective Patient Engagement and Education for Clinical Trials Recruitment and Retention Transcript

Nariman Nasser, Digital Strategist, Genentech

Amid Zand Interview Ms. Nariman Nasser of Genentech, on December 23, 2014. Nariman will be speaking at the SCOPE Summit in Orlando, FL in a track titled managing late stage research, observational studies and registries. Her talk will focus on digital strategies that makes observational studies more accessible and better aligned with patients lives.

Click Here to Download 

Managing Drug Safety Challenges from Clinical Trials to Post Marketing Stages

Sundos Hamza, M.D., Senior Vice President, Drug Safety Risk Management, InterMune

Amid Zand Interview Dr. Sundos Hamza of InterMune on December 12, 2014. In this interview Dr. Hamza speaks about the importance of effective global drug safety risk minimization strategies in clinical and post marketing phases of drug development.

Click Here to Download 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Event-At-A-Glance 

2015 Final Agenda Image 

> Premier Sponsors 

 BBK 

Bio Clinica Logo 

 ClinicalInk 

Drug Dev 

Exostar 

IMS Health  

 Mapi 

Medidata 

OptumInsight

Oracle Health Sciences(1) 

PRA Health Sciences 

QUINTILES
 

> View All Sponsors 

> View Media Partners 

> Attendee Profile